KIAA1429 promotes vascular smooth muscle cell PANoptosis via m6A-dependent PIEZO1/NLRP3 activation in lower extremity arteriosclerosis obliterans
Year: 2026
Type: article
Abstract: Objective Arteriosclerosis obliterans (ASO) involves vascular smooth muscle cell (VSMC) dysfunction, cell death, and vascular inflammation. This study investigated the role of the m 6 A writer KIAA1429 and its downstream mechanosensitive signaling in ASO pathogenesis. Methods Human VSMCs (hVSMCs) were treated with ox-LDL to establish an ASO-like cellular injury model and subjected to KIAA1429 overexpression or knockdown, with Yoda1 used as a PIEZO1 agonist. A candidate PIEZO1 m 6 A site was evaluated using wild-type (WT) and site-mutant (Mut) dual-luciferase reporters together with Actinomycin D decay analysis. Reverse genetic rescue combined KIAA1429 overexpression with PIEZO1 silencing, followed by lipid staining, flow cytometry, cytokine ELISA, NLRP3-ASC co-immunoprecipitation (Co-IP), and profiling of pyroptosis-, apoptosis-, and necroptosis-associated proteins. An in vivo ASO model was established in ApoE - / - mice by high-fat feeding and femoral artery ligation, with SM22α-driven AAV-shKIAA1429 used for VSMC-associated KIAA1429 knockdown; serum cytokines and α-SMA-based arterial immunofluorescence were subsequently analyzed. Results In vitro , ox-LDL significantly upregulated KIAA1429 expression and total m 6 A levels. RIP-qPCR demonstrated an association between KIAA1429 and PIEZO1 mRNA, and KIAA1429 overexpression prolonged PIEZO1 mRNA half-life. KIAA1429 overexpression increased WT PIEZO1 reporter activity and stability, whereas mutation of the candidate m 6 A adenosine markedly blunted this response. PIEZO1 silencing attenuated KIAA1429-overexpression-induced lipid accumulation, apoptosis, IL-1β/IL-18 release, NLRP3-ASC association, and activation of pyroptosis-, apoptosis-, and necroptosis-associated proteins. In vivo , SM22α-mediated KIAA1429 silencing attenuated vascular thickening, lipid deposition, and fibrosis, reduced serum IL-1β/IL-18, and decreased KIAA1429 and PIEZO1 signals within α-SMA-positive arterial regions. Conclusions KIAA1429 exacerbates ASO-associated vascular injury by promoting candidate-site-sensitive m 6 A-associated stabilization of PIEZO1 mRNA, thereby enhancing PIEZO1/NLRP3 signaling and coordinated VSMC inflammatory cell-death programs. The KIAA1429/PIEZO1/NLRP3 axis therefore represents a mechanistically supported candidate target for further ASO investigation.
Source: Frontiers in Immunology
Authors: Erdemutu E.(Conceptualization, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Liqiang Hu(Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Shaohong Yin(Investigation, Writing – original draft, Writing – review & editing), Ying Lan(Investigation, Writing – original draft, Writing – review & editing), Chongbin Zhou(Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Inner Mongolia Medical University, Hohhot First Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234088466
